article thumbnail

How payers can use healthcare data to enhance network adequacy

Clarify Health

Designing and maintaining a healthcare network is no simple task—especially when it comes to meeting the needs for accessibility, quality, and cost across a diverse pool of members. Health plans need to design networks that offer members reasonable access to in-network providers to ensure the network is adequate to meet their health needs.

article thumbnail

What if Bill Clinton & Ronald Reagan Had Debates Universal Government Funded Healthcare? A Fictional Debate Portrayal.

Pharma Marketing Network

Bill Clinton: My fellow Americans, I stand here today to argue in favor of universal government-funded healthcare. This leads to higher healthcare costs for everyone, as emergency room visits and hospital stays are much more expensive than regular doctor visits. appeared first on Pharma Marketing Network.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Data integrity considerations in Pharma and Life Sciences

European Pharmaceutical Review

Life science companies are increasingly using advanced technologies like artificial intelligence (AI), machine learning (ML) and blockchain to improve data quality and integrity by detecting anomalies in data and establishing tamper-proof audit trails for all data-related activities Data governance.

article thumbnail

Webinar recap: How Cigna is Innovating their Network Design Process

Clarify Health

On December 16th, we hosted an AHIP webinar discussion about how Cigna is innovating their network design process for market expansion. Austin has spent the last eight years at Cigna with responsibility for medical economics and analytics, leading the transformation of data and analytics for their government business segment.

article thumbnail

Championing UK ATMP clinical trials

European Pharmaceutical Review

Specifically, an additional four years of funding for the Advanced Therapy Treatment Centre (ATTC) Network is available through the programme. The funding will start with three established Centres, and then across an expanded network, according to Chief Clinical Officer for Cell and Gene Therapy Catapult, Jacqueline Barry.

article thumbnail

Exploring the impact of globalization on research in the United States

Clarivate

remains a leading science and technology power, it must acknowledge its shrinking domestic research capacity and work collaboratively with resourceful competitors to maintain its position. remains a leading science and technology power, it faces increasing competition from new science-based economies in Asia and an expanded EU network.

article thumbnail

Sandoz mobilises critical medicine production in Europe

European Pharmaceutical Review

Sandoz] has the only major remaining vertically-integrated production network for penicillins in Europe” Penicillins are the leading category of antibiotics worldwide, Sandoz highlighted. Financial investment in the Kundl facility includes a €50 million contribution from the Austrian federal government.